Subscribe
Subscribe
Picture of BioVox

BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is powered by Biovia: the health innovation cluster for Flanders.
Picture of BioVox

BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is powered by Biovia: the health innovation cluster for Flanders.

Managing the hype cycle of innovative medical device development

As a CDMO in the life science industry, Unitron has a focus on the development and manufacturing of “electronics-inside” medical devices and the associated regulatory trajectory. The journey from innovative ideas to successful products are often bumpy and filled with challenges. Having a good understanding of this process and managing it well will boost your chances of success.

Obulytix is developing a revolutionary solution for antibiotic resistance

Obulytix, a spin-off based on research results from Ghent University and KU Leuven, has built a platform that creates new ways to tackle bacterial infections. The innovative, phage lysin-based platform – leveraging the power of artificial intelligence – attracted a significant four-million-euro investment from Boehringer Ingelheim Venture Fund, Qbic, and Gemma Frisius Fund.

Azalea Vision announces first on-eye test of ALMA, its revolutionary smart contact lens

In a significant milestone, Azalea Vision, pioneering start-up on a mission to revolutionize the treatment of ocular disorders, announces the successful demonstration of ALMA Lens, the first functional prototype of the Azalea smart contact lens’ platform.

Pioneering Belgian project ATHENA paves the way for Real-World Data reuse in research and personalized care

ATHENA, a VLAIO-funded multi-stakeholder project, clears the path for increased reuse of Real-World Data in scientific research and healthcare, by introducing innovative solutions and responding to current technical and governance challenges. The project has made significant strides in the field of oncology by developing groundbreaking privacy-preserving machine learning techniques for predictive analytics. The project findings will be presented and discussed at the ATHENA symposium on November 23rd, 2023.

Belgium – nurturing innovation at the interface of biology and technology

The ´Science for health´ congress gathers local and global experts in Brussels on November 28 to discuss how to adapt healthcare to current challenges, combining cutting-edge technology with biology and place Belgium at the forefront of healthcare innovation.

Belgian breakthrough in endometriosis research captures investors’ attention

Even though endometriosis impacts millions of women globally, the condition remains poorly understood and researched, leading to delayed diagnosis and lack of effective treatment. Encouragingly, there are promising recent developments in the field coming from Belgium. Professor Hugo Vankelecom’s research group at KU Leuven uses advanced cellular models, known as organoids, to delve into the disease and expedite the drug discovery process. The Danish BioInnovation Institute now offers the team an incubation program to pave the way towards industrial success.

Key steps for impactful communication

New advances in the life sciences shouldn’t be kept in the dark. Whether you are an academic publishing a paper, a researcher with a breakthrough drug, or an entrepreneur with the next big biotech innovation, you want to reach your audience and achieve your goals. However, it can be hard to know how to go about it. So let’s break it down and examine some of the key considerations for impactful science communication.

miDiagnostics announces collaboration with Galapagos to develop closed-flow, ultra-rapid CAR-T sterility test for its point-of-care CAR-T manufacturing platform

Augustine Therapeutics expands its leadership team and R&D platform, enters regulatory development.

Johan Cardoen’s hopes for the future of agriculture

Flanders is home to one of the world’s most innovative agrifood clusters, and Johan Cardoen has been a central figure in that ecosystem for over three decades. From leading positions in agtech startups to the Managing Director of VIB, Cardoen has run the gamut of Flemish biotech. Interested in his decades of firsthand experience in the sector, we spoke with Cardoen about his views on the past, present, and future of sustainable agriculture.

Bar.on presents the world’s first beer printer

Instantly turning water into beer may sound like a biblical miracle, but that’s exactly what Belgian start-up Bar.on is now doing. Their ‘molecular beer printer’ takes mere seconds to turn water into different styles of beer, with customized bitterness, alcohol content, fruitiness, and sweetness. Backed by science, the company is on a mission to make the beer industry more sustainable and hopes to soon roll out its molecular beer mixing technology to different markets.

Career opportunities in the life sciences industry

The pharma, biotech and medtech industries offer a wealth of job and career opportunities, but recent graduates and early-career professionals are often unaware of the many options available to them in the life sciences. This article briefly overviews the many job possibilities in the industry, including a link to a recently published book for those wanting an insider’s guide to further employment prospects.

The QbD Group acquires Turnstone Communications and BioVox to strengthen its specialist science communication and marketing services

Nicky Deasy: how agrifood startups can help us tackle climate change

Nicky Deasy is Co-Founder and former Managing Partner at The Yield Lab Europe, one of the largest early-stage venture capital funds in the EU focused on the intersection of sustainability and agtech. Since stepping back from the day-to-day running of the fund, she is an Investment Committee Member at biotope by VIB, as well as advising a number of startups and investment funds focused on improving the environmental and carbon footprint of the agrifood industry. She shares her thoughts on how innovative ag- and food-tech startups can help us tackle climate change.

eureKARE stimulates synthetic biology start-ups with studio in Belgium

With its network of thematic SynBio Studios, investment company eureKARE is boosting the creation of new European start-ups in synthetic biology. Its first EU studio is located in Brussels and focuses on biomedical applications. Things are moving fast, and the studio has already welcomed two companies onboard.